Delivery Order 36F79723D0126-36C25224N0446
- This is a federal contract award by the U.S. Department of Veterans Affairs (VA) to Avedro, Inc., a subsidiary of Glaukos Corporation, for the delivery of IDOSE TR 75 MGC IMPLANT medical devices. The $10,655.28 firm-fixed-price contract has an ultimate completion date of August 14, 2025. Avedro, Inc. is a for-profit medical device and pharmaceutical manufacturer specializing in advanced ophthalmic technologies. The contract is not set-aside and is part of Avedro's broader Federal Supply Schedule...
- The U.S. Department of Veterans Affairs (VA) has awarded a $21,310.56 firm-fixed-price purchase order contract to Avedro, Inc., a subsidiary of Glaukos Corporation, for the supply of PROS IMPLANT medical devices. The contract, which has an ultimate completion date of May 18, 2025, was awarded on April 18, 2025 and is not designated as a set-aside. Avedro, Inc. is a for-profit medical device and pharmaceutical manufacturer specializing in advanced ophthalmic products. The company has been awarded...
- This is a firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Avedro, Inc., a subsidiary of Glaukos Corporation, a for-profit manufacturer of medical goods. The contract is for the delivery of IDOSE TRAVOPROST 75MCG IMPLANT, a specialized ophthalmic product, with a ceiling value of $213,105.60. The contract was awarded on July 10, 2024, with a period of performance ending on November 15, 2024. This order is placed under Avedro, Inc.'s existing...
- This federal contract award is for the procurement of IDOSE TR 75MCG IMPLANT TRADE medical devices by the U.S. Department of Veterans Affairs (VA). The prime contractor is Avedro, Inc., a subsidiary of Glaukos Corporation, a for-profit medical device manufacturer specializing in ophthalmic products. The contract is a firm-fixed-price delivery order with a ceiling value of $21,310.56 and an ultimate completion date of January 31, 2026. This award is not associated with a set-aside designation,...
- This federal contract award, with ID 36C25924P1445, was granted to Avedro, Inc., a for-profit manufacturer of medical devices and pharmaceuticals, particularly ophthalmic products. The contract, valued at $21,310.56, is for the delivery of PROS IMPLANTS to the Veterans Integrated Service Network 19 (VISN 19), a civilian agency within the U.S. Department of Veterans Affairs. The contract type is a Firm Fixed Price purchase order, and there is no set-aside designation, indicating full and open...
- This is a $91,400.00 firm-fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Avedro, Inc., a for-profit manufacturer of medical devices and pharmaceuticals. The contract is for the delivery of KXL FINISHED ASSEMBLY medical products, which are likely specialized ophthalmic implants or pharmaceutical solutions. The contract has a total small business set-aside designation and an ultimate completion date of August 15, 2017. Avedro, Inc. is a...
- This is a firm-fixed-price purchase order awarded by the Defense Health Agency (DHA) to Avedro, Inc., a for-profit manufacturer of medical devices and pharmaceuticals. The contract has a ceiling value of $85,900.00 and an ultimate completion date of April 24, 2017. The contract is for the delivery of an AVEDRO KXL DEVICE, which is a medical device used for ophthalmic procedures. Avedro, Inc. is a subsidiary of Glaukos Corporation, another medical device manufacturer, and has an established...
- This federal contract award was issued by the Defense Health Agency (DHA), a defense agency, to Avedro, Inc., a for-profit manufacturer of medical devices and pharmaceuticals, particularly ophthalmic products. The contract, a $85,900.00 firm-fixed-price purchase order, is for the delivery of a KXL Device, 110-02723. The contract does not have a set-aside designation, indicating it was competed on a full and open basis. Avedro, Inc. is a subsidiary of Glaukos Corporation and has an established...
- This is a firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 16 (VISN 16), a division of the U.S. Department of Veterans Affairs (VA), to Avedro, Inc., a for-profit manufacturer of medical devices and pharmaceuticals. The contract is for the provision of a Corneal Crosslinking Device, with a ceiling value of $89,400.00 and a period of performance ending on July 13, 2017. The contract was set aside for small businesses. Avedro, Inc. holds two Federal Supply...
- This firm-fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) to Glaukos Corporation, a for-profit medical device manufacturer, for the provision of a prosthetic surgical implant for the right eye. The contract award, valued at $21,340.56, has an ultimate completion date of May 30, 2025. The contract is not set aside and was awarded through the Veterans Integrated Service Network 23 (VISN 23). Glaukos Corporation, through its subsidiary Avedro, Inc., also holds...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79723D0126Federal Supply Schedule
- 36F79723D0126-36C25224N0446Delivery Order
Avedro, Inc., a subsidiary of Glaukos Corporation specializing in ophthalmic medical devices, was awarded a firm fixed-price delivery order valued at $95,897.52 by Veterans Integrated Service Network 12 on June 15, 2024, for IDOSE TR 75 CMG implants. This delivery order, which is not set-aside designated, is issued under the parent Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, enabling streamlined procurement of specialized medical products. The contract specifies performance at Avedro's Waltham, Massachusetts facility, with an ultimate completion date of June 14, 2025. The delivery order supports the Department of Veterans Affairs' ophthalmic healthcare requirements through Avedro's established expertise in advanced eye-care implant technologies. As a pre-approved supplier under the GSA schedule framework, Avedro has demonstrated consistent capability to deliver specialized pharmaceutical and medical device solutions across multiple Veterans Integrated Service Networks. This procurement represents part of the VA's broader strategy to secure innovative ophthalmic treatments for veteran populations through competitive, streamlined acquisition mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($139k) | 1/30/26 | |
| Not listed | Not listed | $234.4k | 6/13/24 |